Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities    
Net loss $ (9,975,850) $ (12,290,643)
Stock-based compensation:    
401(k) stock 5,908 26,360
Common stock 150,000 525,000
Stock options and warrants 95,578 223,246
Restricted stock units 305,045 158,671
Noncash lease expense 171,933 162,148
Gain on foreign currency translation (347,201) (411,178)
Depreciation and amortization 337,433 178,896
Amortization of debt discount 2,104,384 1,078,731
Provision for credit losses 112,289 67,295
Provision for obsolete inventory 123,225 115,563
Change in fair value of derivative liability 2,236,844
Loss on extinguishment of debt 416,081 2,105,119
Inducement expense 3,163,318
Decrease (increase) in assets:    
Accounts receivable and mortgages receivable (176,542) (314,065)
Employee advances (8,082) 4,579
Inventory (611,752) (385,686)
Deposits 1,336
Prepaid expenses and other current assets 103,075 (100,513)
Increase (decrease) in liabilities:    
Accounts payable and accrued expenses (9,778) 866,987
Operating lease liabilities (149,994) (128,549)
Deferred revenue 150,859 542,578
Other liabilities (19,154) (71,983)
Total Adjustments 4,991,487 7,806,517
Net Cash Used in Operating Activities (4,984,363) (4,484,126)
Cash Flow from Investing Activities    
Cash paid to acquire GDS, net of cash acquired (7,560)
Purchase of property and equipment (580,120) (1,915,952)
Purchase of intangible asset (50,000) (34,999)
Net Cash Used in Investing Activities (630,120) (1,958,511)
Cash Flow from Financing Activities    
Proceeds from loans payable 185,000
Repayments of loans payable (87,217) (81,431)
Proceeds from the issuance of convertible debt 5,000,000 1,727,500
Financing costs in connection with the issuance of convertible debt (321,802)
Repayments of convertible debt obligations (862,541)
Redemption premiums paid on convertible debt obligations (156,161)
Repayments of debt obligations (7,000)
Proceeds from common stock issued for cash 996,000 511,346
Proceeds from issuance of shares under the New ELOC, net of offering costs [1] 775,639
Net Cash Provided by Financing Activities 5,528,918 2,150,415
Effect of Exchange Rate Changes on Cash (13,512) 903,799
Net Decrease in Cash (99,077) (3,388,423)
Cash - Beginning of Period 300,185 3,649,407
Cash - End of Period 201,108 260,984
Supplemental Disclosures of Cash Flow Information:    
Interest paid 1,011,650 175,252
Income taxes paid
Non-Cash Investing and Financing Activity    
Equity issued to satisfy accrued stock based compensation obligation 32,617 27,821
Equity issued as consideration for intangible assets 39,600
Equity issued for purchase of non-controlling interest 231,789
Equity issued for acquisition of GDS 2,194,653
Warrants issued and debt principal exchanged upon modification of convertible debt 834,323
Shares issued upon conversion of debt and interest 2,821,820 6,460,243
Common stock and restricted stock units in GGH issued upon exchange of GGI options 1,576,648
Cashless warrant exercise 51
Relative fair value of warrants issued with 2023 Notes, net of allocable issuance costs [2] 1,506,319
Warrants issued and debt principal exchanged upon modification of convertible debt 63,502
Debt discount for warrant modification $ 392,273
[1] Gross proceeds of $850,611, less offering costs of $74,972
[2] Represents $1,609,935 relative fair value of warrants, less $103,616 in allocable issuance costs